TMC The Metals Co (NASDAQ:TMC) 주식

TMC Metals

TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.

Trading,Chart,Displayed,On,The,Screen,Of,The,Laptop.,Stock

Equities

News

Markets

APLD

PLTR

RKLB

TSLA

월요일(14일) 미국 증시는 긍정적인 모습이었다. 나스닥 종합지수는 0.6% 상승하여 16,831.48포인트에 마감했다. S&amp;P 500도 0.80% 상승하여 5,405.97포인트에 마감했다. 다우존스는 0.8% 상승하여 40,524.79포인트에 도달했다.

월요일 주목받은 주식: 팔란티어, MP머티리얼즈, 어플라이드 디지털, 로켓랩 및 테슬라

lithium field ai

Commodities

AAUKF

FMST

2024년 5월 23일 주요 뉴스: 포모스트 리튬(NASDAQ:FMST): 밴쿠버에 본사를 둔 이 회사는 조로(Zoro) 부지에서 2024년 겨울 탐사 프로그램을 완료하여 21개의 다이아몬드 드릴 홀에 걸쳐 5,800미터가 넘는 작업을 달성했다.

목요일 주요 광업 뉴스; 포모스트 리튬, 메탈스 컴퍼니, 부에나벤투라 마이닝, BHP

TMC the metals company Inc. - Common Stock

TMC The Metals Co Inc

TOMCO ENERGY PLC NEW ORD by TomCo Energy Plc

TomCo Energy PLC

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts Inc

TEMECULA VALLEY BNCRP INC by Temecula Valley Bancorp, Inc.

Temecula Valley Bancorp Inc

<a href="https://www.wsj.com/tech/apple-to-delay-some-feature-rollouts-in-eu-citing-regulatory-hurdles-f2965097">https://www.wsj.com/tech/apple-to-delay-some-feature-rollouts-in-eu-citing-regulatory-hurdles-f2965097</a>

General

AAPL

'Apple to Delay Some Feature Rollouts in EU, Citing Regulatory Hurdles'- WSJ

Zscaler Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) shares are falling Monday after the company announced a proposed offering of <a href="https://www.benzinga.com/pressreleases/25/06/g46164848/zscaler-announces-proposed-offering-of-1-5-billion-of-convertible-senior-notes-due-2028">convertible senior notes</a>. 
What Happened: Cybersecurity firm Zscaler said it intends to offer $1.5 billion of convertible senior notes due 2028 in a private offering to institutional investors. The company also expects to grant the initial purchasers a 13-day window to purchase up to an additional $225 million of the notes. 
Zscaler expects to use some of the proceeds to pay the cost of capped call transactions in connection with the notes. The remainder will be used for general corporate purposes, which may include working capital, capital expenditures and potential acquisitions or strategy transactions. 
Zscaler had approximately $3.01 billion in cash, cash equivalents and short-term investments as of April 30.
<h3 class="wp-block-heading">How To Buy ZS Stock</h3>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Zscaler's case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
ZS Price Action: <a href="http://benzinga.com/quote/ZS">Zscaler shares</a> were down 2.02% at $308.96 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/m-a/25/06/46167555/why-is-hewlett-packard-stock-soaring-on-monday">Why Is Hewlett Packard Stock Soaring On Monday?</a></li>
</ul>
Photo: Sundry Photography/Shutterstock.com

Offerings

Zscaler Stock Is Sliding Today: Here's Why

Strategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), formerly known as MicroStrategy, has added another 4,980 Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) to its treasury over the past week, spending approximately $531.9 million at an <a href="https://in.benzinga.com/crypto/cryptocurrency/25/06/46148645/bitcoin-heavyweight-strategy-faces-multiple-securities-fraud-lawsuits-over-btc-treasury-disclosures-report">average price of $106,801 per Bitcoin</a>, according to a regulatory filing with the U.S. Securities and Exchange Commission.
As of June 29, Strategy <a href="https://assets.contentstack.io/v3/assets/bltf8d808d9b8cebd37/blt9881a4184cc6914d/68627916b77630517afe221c/form-8-k_06-30-2025.pdf">holds </a>a total of 597,325 Bitcoin acquired for roughly $42.40 billion, with the average purchase price standing at approximately $70,982 per Bitcoin.
The company also disclosed that it has achieved a 19.7% year-to-date Bitcoin yield in 2025.
Strategy financed this recent Bitcoin purchase using proceeds from its active at-the-market (ATM) stock and preferred share offerings. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46166208/bitcoin-etfs-extend-record-2-2b-net-inflows-to-extend-streak-to-11-weeks">Bitcoin ETFs Extend Record $2.2B Net Inflows To Extend Streak To 11 Week</a>
Between June 23 and June 29, the company raised approximately $578.1 million across its Class A common stock (MSTR), 8.00% Series A perpetual strike preferred stock (STRK), and 10.00% Series A perpetual strife preferred stock (STRF) programs.
The company's Bitcoin acquisition strategy, heavily funded through stock and preferred share issuances, remains a central part of its corporate treasury approach. 
The firm continues to actively use ATM offerings to support both its Bitcoin purchases and dividend payments on its preferred shares.
Strategy also confirmed it paid out quarterly dividends on June 30, funded via net proceeds from its Common ATM sales.
The company maintains that its treasury strategy is focused on long-term Bitcoin accumulation, positioning itself as one of the largest corporate holders of Bitcoin globally.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46165366/circle-stock-is-a-must-hold-says-bernstein-heres-why">Circle Stock Is A &#8216;Must Hold,&#8217; Says Bernstein: Here&#8217;s Why</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

Strategy Adds 4,980 Bitcoin, Ups Total Stack To $42 Billion

Morgan Stanley analyst Toni Kaplan maintains Aramark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARMK#NYSE">ARMK</a>) with a Equal-Weight and raises the price target from $42 to $44.

Price Target

Analyst Ratings

ARMK

Morgan Stanley Maintains Equal-Weight on Aramark, Raises Price Target to $44

Macro Economic Events

Macro Notification

Politics

Economics

U.S. Treasury's Bessent Says Countries Should Be Aware That We Could Spring Back To April 2 Levels On Tariffs; Any Tariff Negotiating Extension Will Be Up To Trump

WIIM

NLSP

NLSP stock has given up its prior gain. NLS Pharmaceutics shares were trading higher after the company announced it completed its second and final equity financing round consisting of preferred shares and warrants worth $3 million in total.

Mizuho analyst Anthony Crowdell upgrades Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) from Neutral to Outperform and raises the price target from $105 to $107.

Upgrades

Mizuho Upgrades Consolidated Edison to Outperform, Raises Price Target to $107

U.S. Treasury's Bessent Says We Have Given Consideration To January Fed Board Appointee Could Eventually Become Chair; Fed Made 'Gigantic' Mistake In 2022 On Rates; We Have Seen No Inflation From Tariffs, There Could Be One-time Price Adjustment

WLGS

Wang & Lee Group shares are trading lower after the company announced it received a Nasdaq delisting notice.

VERI

Veritone shares are trading lower after the company announced its offering raised $10 million through the sale of stock and pre-funded warrants.

Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) on Monday revealed results from a Phase 3 efficacy study (P304) evaluating the relative vaccine efficacy (rVE) against influenza illness of mRNA-1010, the company&#8217;s seasonal influenza (flu) vaccine candidate, compared to a licensed standard-dose seasonal influenza vaccine in adults <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">aged 50 years and older</a>.
mRNA-1010 achieved the most stringent superiority criterion prespecified in the protocol, with an rVE of 26.6% in the overall study population. Additionally, strong rVE was observed for each influenza strain contained in the vaccine, including A/H1N1 (rVE=29.6%), A/H3N2 (rVE=22.2%), and the B/Victoria lineages (rVE=29.1%).
Subgroup analyses confirmed a consistently strong rVE point estimate across age groups, risk factors, and previous influenza vaccination status. In participants aged 65 years and older, mRNA-1010 demonstrated <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/ac46164898/moderna-announces-positive-phase-3-results-for-seasonal-influenza-vaccine" rel="noreferrer noopener">an rVE of 27.4%</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/45887132/novavaxs-experimental-covid-19-influenza-combo-shot-shows-immune-response-among-older-adults-in-phase-3-trial" rel="noreferrer noopener">Novavax&#8217;s Experimental COVID-19-Influenza Combo Shot Shows Immune Response Among Older Adults In Phase 3 Trial</a>
In a previous Phase 3 study, mRNA-1010 had demonstrated superior seroconversion rates and geometric mean titer ratios (GMR) against all strains included in the vaccine compared to both high-dose and standard-dose licensed seasonal influenza vaccine.
According to the CDC, seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-2025 season.
Over 600,000 Americans were hospitalized due to flu-related illness last year, leading to substantial direct and indirect costs and widespread disruption to daily life and work.
The trial enrolled 40,805 adults aged 50 years and older across 11 countries. Participants were randomly assigned to receive either a single dose of mRNA-1010 or a standard-dose licensed comparator, with a median follow-up of six months.
The safety and tolerability of mRNA-1010 were consistent with reported results from a previous Phase 3 study. The majority of solicited adverse reactions (SARs) were mild.
Injection site pain was the most common local SAR, and fatigue, headache, and myalgia were the most common systemic SARs reported.
There were no significant differences between the groups in the rates of unsolicited adverse events, serious adverse events, or adverse events of special interest.
Moderna plans to present these data at an upcoming medical conference and submit them for peer-reviewed publication. The company will engage with regulators on filing submissions for mRNA-1010.
Earlier this month, the U.S. Food and Drug Administration (FDA) expanded approval of Moderna&#8217;s respiratory syncytial virus vaccine to adults aged 18-59 at <a target="_blank" href="https://www.benzinga.com/news/health-care/25/06/45921359/fda-expands-modernas-rsv-vaccine-use-to-at-risk-adults-aged-18-59-amid-cdc-panel-shake-up" rel="noreferrer noopener">increased risk for disease</a>.
The mRNA-based shot showed significant immune responses in adults with underlying health conditions and maintained a favorable safety profile. The vaccine was previously limited to adults 60 and older, where it demonstrated 79% efficacy against RSV symptoms.
Price Action: MRNA stock is up 3.31% at $28.06 during the premarket session at last check Monday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/fda/25/06/46166652/fda-eases-access-to-life-saving-gene-therapies-for-blood-cancers" target="_blank" rel="noreferrer noopener">FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers</a></li>
</ul>
Image via Shutterstock

Biotech

Large Cap

Health Care

Movers

MRNA

Moderna's mRNA Flu Vaccine Outperforms Standard Shots

Mizuho analyst Steven Valiquette initiates coverage on Waystar Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAY#NASDAQ">WAY</a>) with a Outperform rating and announces Price Target of $48.

Initiation

Mizuho Initiates Coverage On Waystar Holding with Outperform Rating, Announces Price Target of $48

TRUG

TRUG stock has given up its prior gain. TruGolf shares were trading higher after the company announced the launch of its LaunchBox launch monitor.

Donald Trump has been in office for <a href="https://www.benzinga.com/general/entertainment/25/01/43139381/how-many-people-watched-donald-trumps-2025-inauguration-spoiler-less-than-biden-four-years-ago">less than six months</a> of his four-year term. That doesn't stop voters from looking to the 2028 election with polls and betting odds showing a mix of candidates for both the Republican and Democratic parties.
New 2028 Election Poll: A new 2028 presidential election poll shows the odds for candidates for both of the major parties with many question marks remaining, including if Kamala Harris <a href="https://www.benzinga.com/25/01/43111443/2028-election-betting-odds-where-do-jd-vance-kamala-harris-michelle-obama-donald-trump-jr-rank">will run again </a>after losing to Trump in the 2024 election.
The Emerson College <a href="https://emersoncollegepolling.com/june-national-poll/">poll </a>found the following top candidates for voters for the Democratic party.
<ul class="wp-block-list">
<li>Pete Buttigieg: 16%</li>
<li>Kamala Harris: 13%</li>
<li>Gavin Newsom: 12%</li>
<li>Alexandria Ocasio-Cortez: 7%</li>
<li>Josh Shapiro: 7%</li>
<li>Undecided: 23%</li>
</ul>
Harris previously led the race in a November poll from Emerson College, for which voters wrote in their preferred candidate. Newsom ranked second at the time with 7% and Buttigieg was third with 4%. Undecided received a larger portion with 35% of the vote back in November.
On the Republican party side of things, here's how the latest poll came out for the potential candidates and the percentage of voters who selected them as the preferred party candidate.
<ul class="wp-block-list">
<li>JD Vance: 46%</li>
<li>Marco Rubio: 12%</li>
<li>Ron DeSantis: 9%</li>
<li>Robert F. Kennedy Jr.: 5%</li>
<li>Kristi Noem: 2%</li>
<li>Nikki Haley: 2%</li>
<li>Undecided: 17%</li>
</ul>
Vance led the way with a near majority in the latest poll. This was up from 30% in the poll back in November. Voters are becoming more clear on their picks with the number of undecided voters in the party dropping from 50% in November to 17% in June.
A generic election poll asked which party voters would likely side with in the 2028 election. That poll was split evenly: 42% Republicans and 42% Democrats with 16% undecided. In the poll, Independents were more likely to side with the Democratic Party at 37% to 29%, with 34% undecided.
Did You Know?
<ul class="wp-block-list">
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent062725">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
Betting Odds: Here are the June odds from <a href="https://sports.betmgm.ca/en/blog/us-presidential-election-odds/us-presidential-election-betting-odds-predictions-bm17/">BetMGM</a>, which is a unit of MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>). U.S. residents can not currently bet on the election with BetMGM. Odds from January are listed in parentheses.
<ul class="wp-block-list">
<li>JD Vance: +250 (+275)</li>
<li>Gavin Newsom: +1,000 (+650)</li>
<li>Alexandria Ocasio-Ortez: +1,400 (+2,500)</li>
<li>Josh Shapiro: +1,600 (+800)</li>
<li>Donald Trump Jr.: +1,600 (+3,300)</li>
<li>Pete Buttigieg: +1,800 (+1,400)</li>
<li>Gretchen Whitmer: +2,000 (+1,600)</li>
<li>Michelle Obama: +2,500 (+800)</li>
<li>Ron DeSantis: +2,500 (+1,000)</li>
<li>Nikki Haley: +2,500 (+2,500)</li>
<li>Robert F. Kennedy Jr.: +4,000 (+3,300)</li>
<li>Kamala Harris: +5,000 (NA)</li>
</ul>
Vance's odds have improved in the latest betting odds and he remains the Republican frontrunner. Many Democratic candidates have seen their odds drop as no official candidates have entered the race and it is considered fairly wide open.
Read Also: <a href="https://www.benzinga.com/news/politics/25/06/46106134/bernie-sanders-shares-first-thing-he-would-do-as-president-and-it-could-be-a-jab-at-elon-musk">Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk</a>
Prediction Markets: Kalshi, which is legal to U.S. bettors, has several betting <a href="https://kalshi.com/?search=2028%20election">markets </a>open for 2028, including the winning party, which candidates will announce they're running, vice presidential nominations, whether Elon Musk will support the Democrats and who will win the election.
Overall, the prediction markets shows the Democratic Party favored to win at 52% to 48%, compared to 51% to 49% in January.
Here are the betting odds on Kalshi for the GOP nominee for the 2028, with odds from January in parentheses:
<ul class="wp-block-list">
<li>JD Vance: 41% (44%)</li>
<li>Marco Rubio: 8% (5%)</li>
<li>Tulsi Gabbard: 8% (Under 4%)</li>
<li>Glenn Youngkin: 7% (Under 4%)</li>
<li>Donald Trump: 7% (7%)</li>
<li>Ron DeSantis: 5% (6%)</li>
<li>Donald Trump Jr.: 5% (6%)</li>
<li>Nikki Haley: 3% (Under 4%)</li>
</ul>
The 22nd&nbsp;Amendment currently would keep Trump from serving more than two terms in the White House, but he's included in Kalshi's odds here.
Here are the betting odds on Kalshi for the Democrat Party nominee for the 2028 election, with odds from January in parentheses:
<ul class="wp-block-list">
<li>Gavin Newsom: 15% (14%)</li>
<li>Alexandria Ocasio-Cortez: 13% (8%)</li>
<li>Pete Buttigieg: 9% (8%)</li>
<li>Josh Shapiro: 7% (13%)</li>
<li>Wes Moore: 7% (7%)</li>
<li>Kamala Harris: 4% (5%)</li>
<li>Gretchen Whitmer: 3% (6%)</li>
</ul>
 Why It Matters: The 2024 presidential election could go down as the political event that changed prediction markets forever.&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41694948/trump-polymarket-whale-has-30m-bet-on-former-president-winning-2024-election-my-intent-is-" target="_blank" rel="noreferrer noopener">Billions of dollars were</a>&nbsp;wagered on&nbsp;Polymarket&nbsp;and CFTC-regulated market Kalshi.
Polymarket, which <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41694948/trump-polymarket-whale-has-30m-bet-on-former-president-winning-2024-election-my-intent-is-" target="_blank" rel="noreferrer noopener">had many prediction markets</a> for the 2024 election, does not currently offer 2028 <a href="https://polymarket.com/markets?_q=2028%20election">markets</a>. The decentralized platform allows users to deposit funds using USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) via the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">POL</a>) network or directly from a crypto account with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>). The platform will be closely watched in the coming months to see who takes the early lead in the 2028 election betting.
While Vance's betting odds and some of Rubio's betting odds may be reflective of voter polls listing the two as the top Republican party choices, betting odds don't match up with the latest Democratic voter poll.
Buttigieg and Harris rank as the top two candidates for Democrats in the poll, but in betting odds and prediction markets are priced lower than other candidates.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/topics/25/05/45186027/donald-trump-weighs-in-on-third-term-speculation-i-dont-know-if-its-constitutional">Donald Trump Weighs In on Third-Term Speculation: &#8216;I Don&#8217;t Know If It&#8217;s Constitutional&#8217;</a></li>
</ul>
Photos: Shutterstock

Sports Betting

$ETH

$POL

$USDC

USDC

2028 Election Poll Shows Vance, Buttigieg In Lead: Where Trump, Newsom, Harris Rank — And Betting Odds

BGFV

Big 5 Sporting Goods shares are trading higher after the company announced it will be acquired for approximately $112.7 million.

U.S. Treasury's Bessent Asks Why Would We Borrow Longer Term At These Rates; We Could See A Lowering Of Rates, Inflation Is 'Very Tame'; Asked About Speculation Over Fed Chair, Says I Will Do Whatever The President Wants But I Have Best Job In Washington

Vor Biopharma shares are trading higher after HC Wainwright & Co. upgraded the stock from Neutral to Buy and announced a price target of $3.

Loop Capital analyst Ananda Baruah maintains TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) with a Buy and raises the price target from $150 to $160.

Loop Capital Maintains Buy on TD Synnex, Raises Price Target to $160

LIDR

AEye shares are trading higher after the company announced that its Apollo Lidar secured an OEM deal worth $30 million.

AIRT

Air T shares are trading lower after the company reported a year-over-year decrease in Q4 financial results.

Management

Press Releases

Rutger Bosland, Pioneering Engineer and Technical Lead on Development of TMC's Nodule Collection System, Joins Company to Drive Commercial Readiness

TMC Welcomes U.S. Executive Order to Expedite Permitting and Evaluate Offtake of Critical Minerals from Nodules in the High Seas

World First: TMC USA Submits Application for Commercial Recovery of Deep-Sea Minerals in the High Seas Under U.S. Seabed Mining Code

TMC CEO Testifies Before Congress: Deep-Sea Minerals Key to U.S. Industrial Future

The Metals Company Announces First Quarter 2025 Corporate Update Conference Call for Wednesday, May 14, 2025

Financing

TMC Announces $37 Million Strategic Investment to Advance Deep-Sea Mineral Development

Earnings

TMC Provides First Quarter 2025 Corporate Update

TMC and Nauru Announce Updated Sponsorship Agreement for Nauru Ocean Resources Inc. (NORI)

TMC Announces Strategic Investment from Korea Zinc — a World-Leader in Non-Ferrous Metal Refining and pCAM Technology — to Advance Development of Deep-Seabed Critical Minerals in the U.S.

TMC Announces Appointment of Michael Hess and Alex Spiro to its Board of Directors

American Battery Technology Company - Common Stock

American Battery Tech

BHP Group Limited American Depositary Shares (Each representing two Ordinary Shares)

Comments

TMC The Metals Co

뉴스

파트너 / 기고자

벤징가 글로벌